📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
18
SER Latest News & AI Sentiment Analysis
1 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Serina Therapeutics (SER), a clinical-stage biotech company, announced participation in the BTIG Virtual Biotechnology Conference...
Serina Therapeutics Appoints Farrell Simon to its Board of Directors
Serina Therapeutics announced a board appointment of Dr. Farrell Simon, a pharmaceutical industry executive with extensive regulatory...
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Serina Therapeutics (SER) has completed sentinel dosing in Cohort 1 of its Phase 1b registrational trial for SER-252, a therapeutic...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice